Skip to main content
Clinical Trials/NL-OMON53388
NL-OMON53388
Not yet recruiting
Phase 2

IMPROVE - improving anxiety treatments by modulating emotional memories prior to in vivo exposure: a multiple baseline study - IMPROVE: improving anxiety treatments

niversiteit Utrecht0 sites8 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Social anxiety (anxiety in social situations)
Sponsor
niversiteit Utrecht
Enrollment
8
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patients \>\=18 years of age
  • \- Sufficient mastery of the Dutch language and ability to complete
  • questionnaires and understand informed consent information
  • \- Meeting DSM\-5 criteria for social anxiety disorder (assessed with
  • MINI\-S\-DSM\-5\).
  • \- Stable medication for at least six weeks before starting participation in the
  • study and willingness by the patient and physician to keep the medication
  • stable during the study period. The use of sedating medication (e.g.
  • benzodiazepines) is no contraindication however, participants are strongly
  • advised not to use sedating medication prior to\- or after treatment sessions

Exclusion Criteria

  • \- Self\-reported neurological disorder
  • \- Acute or recent history of suicide attempts according to the (MINI\-S\-DSM\-5\)
  • \- Self\-reported visual or auditory impairments that could hinder treatment
  • \- Self\-reported current psychological treatment for other DSM\-5 disorders
  • \- Being reluctant or unable to complete questionnaires online

Outcomes

Primary Outcomes

Not specified

Similar Trials